Abaloparatide

Sold as Tymlos. Every FDA application for this active ingredient.

First approved: Apr 28, 2017
Applications: 1
New uses approved: 4
Complete response letters: 0

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Apr 28, 2017	TymlosNDA 208743 · New molecular entity	Radius	10	Marketed

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Drugs@FDA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.